Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -1.46% | -8.16% | -15.09% |
01/05 | HC Wainwright Starts Cyclo Therapeutics With Buy Rating, $3 Price Target | MT |
18/03 | Cyclo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.09% | 3.93Cr | |
+32.07% | 69TCr | |
+29.39% | 59TCr | |
-1.47% | 37TCr | |
+20.12% | 33TCr | |
+7.27% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.34% | 17TCr |
- Stock Market
- Equities
- CYTH Stock
- News Cyclo Therapeutics, Inc.
- Cyclo Therapeutics Signs $5 Million Funding Deal with Rafael Holdings